Joshua Speed, PhD (Nephrology) just received a $1 million K99/R00 award from the National Heart, Lung, and Blood Institute for his project, “Endothelin--Mechanisms in Hypertension and Obesity.” His mentor is David Pollock, PhD.

William Geisler, MD (Infectious Diseases) recently published “Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection” in The New England Journal of Medicine. Read the UAB news article here

The 2015 Department of Medicine Holiday Party was an evening to remember. We kicked off by celebrating the establishment of the Carl E. Dukes, MD, Minority Residency Pipeline Endowed Support Fund. Then we turned our attention to dining and dancing in the spirit of the season. Thanks to all who made the occasion merry and bright!

The Department commends Mary Margaret Basham, MD (PGY-3) for the extraordinary patient care she recently provided to a woman admitted with chest pain and a history of colon cancer who developed a gastrointestinal perforation. Dr. Basham diligently wrote cross-cover notes that were impressive in their detail, and we are proud to salute her attentiveness to both her patient and the medical record.

Final results from the landmark NIH-sponsored Systolic Blood Pressure Intervention Trial (SPRINT) have been published in the New England Journal of Medicine and were presented during the American Heart Association 2015 Scientific Sessions in Orlando. The results are in part products of work conducted by UAB investigators, including Suzanne Oparil, MD (Cardiovascular Disease) Cora E. Lewis, MD (Preventive Medicine) David A. Calhoun, MD (Cardiovascular Disease) Stephen P. Glasser, MD (Preventive Medicine) and Virginia G. Bradley, PhD (Gerontology, Geriatrics and Palliative Care). The study demonstrates that treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including death due to cardiovascular disease, heart failure, stroke and heart attack, by 25 percent.